The closer we get to final FDA approval the more exciting this gets. Not only for the millions of people that suffer from pain but soon Biel will begin a rapid advancement in its share price. Soon the challenge for Biel will be keeping up with demand once the products are aggressively marketed. By this time next year we will be in high cotton.